tiprankstipranks
Trending News
More News >
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market
Advertisement

Assertio Therapeutics (ASRT) Income Statement

Compare
1,157 Followers

Assertio Therapeutics Income Statement

Last quarter (Q3 2025), Assertio Therapeutics's total revenue was $49.46M, an increase of 69.36% from the same quarter last year. In Q3, Assertio Therapeutics's net income was $11.45M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 124.96M$ 152.07M$ 156.23M$ 111.01M$ 108.08M
Gross Profit
$ 85.73M$ 125.05M$ 137.49M$ 95.18M$ 92.30M
Operating Expenses
$ 110.21M$ 368.58M$ 98.08M$ 85.76M$ 174.46M
Depreciation and Amortization
$ 25.83M$ 28.23M$ 33.40M$ 29.11M$ 26.43M
EBITDA
$ 5.15M$ 53.17M$ 90.17M$ 38.78M$ -16.28M
Operating Income
$ -24.48M$ -243.54M$ 39.41M$ 9.42M$ -82.16M
Other Income/Expenses
$ 2.95M$ -10.52M$ -8.24M$ -9.98M$ 71.38M
Pretax Income
$ -21.53M$ -254.05M$ 31.17M$ -553.00K$ -10.78M
Net Income
$ -21.58M$ -331.94M$ 109.63M$ -1.28M$ -28.14M
Per Share Metrics
Basic EPS
$ -0.23$ -4.67$ 2.33$ -0.03$ -1.07
Diluted EPS
$ -0.23$ -4.67$ 2.03$ -0.03$ -1.07
Weighted Average Shares Outstanding
95.27M 71.03M 47.00M 43.17M 26.21M
Weighted Average Shares Outstanding (Diluted)
95.27M 71.03M 54.67M 43.17M 26.21M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis